Pregnancy, delivery, and neonatal outcomes among women with PCOS and endometriosis: a population database cohort

article OA: closed CC0
AI-generated summary by claude@2026-06+body, 2026-06-08

This study compared pregnancy, delivery, and neonatal outcomes in women with both PCOS and endometriosis versus those with PCOS alone, finding increased risks of placental abruption, C-section, DVT, and VTE in the combined group.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-14 · read from full text

This retrospective population-based cohort study used ICD-9 coded data from the HCUP-NIS database (2004–2014) to compare pregnancy, delivery, and neonatal outcomes in women with PCOS plus endometriosis (n=163) versus women with PCOS without endometriosis (n=14,719), including only one delivery per subject and adjusting for confounding via binary logistic regression. Concomitant endometriosis was associated with a demographic profile more often White, lower BMI (<30 kg/m2), and lower income quartiles, and the study group had higher rates of placental abruption (aOR 3.01), Cesarean section (aOR 1.75), and thromboembolic outcomes including deep venous thrombosis (aOR 74.31) and venous thromboembolism (aOR 10.40). The authors note that because little prior work has evaluated combined PCOS and endometriosis pregnancy risk, it is difficult to counsel patients on risks based on existing evidence. This paper is centrally about endometriosis — it evaluates pregnancy, delivery, and neonatal outcomes in women with concomitant endometriosis and PCOS using a population database.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

PURPOSE: PCOS and endometriosis are independent risk factors for perinatal outcomes. Little research has evaluated the concomitant effects of these conditions, nor have studies been conducted on a population database. We sought to identify the pregnancy, delivery, and neonatal outcomes in women with polycystic ovary syndrome (PCOS) and endometriosis vs. PCOS without endometriosis. METHODS: A retrospective population-based cohort study was performed extracting data using ICD-9 codes from the HCUP-NIS Database from 2004 to 2014. Endometriosis in women with PCOS represented the study group (n = 163), and the remaining PCOS, non-endometriosis patients constituted the reference group (n = 14,719). Subjects were included once per delivery. Demographics were compared using chi-squared tests. Confounding effects in pregnancy outcomes were controlled using binary logistic regression analysis. RESULTS: Concomitant endometriosis and PCOS patients were more likely to be white (88.5% vs.71.0%, p < 0.001), with BMI < 30 kg/m2 (87.1% vs.77.8%, p < 0.004) and from lower income quartiles (27.1% vs.17.1%, p < 0.017) when compared to PCOS without endometriosis. Comparing pregnancy complication rates, placental abruption (p < 0.018, aOR 3.01, 95% CI 1.21-7.50), Cesarean section (p < 0.003, aOR 1.75, 95% CI 1.21-2.53), deep venous thromboses (p < 0.002, aOR 74.31, 95% CI 4.57-1209.21), and venous thromboembolic events (p < 0.031, aOR 10.40, 95% CI 1.24-87.37), were increased in the study group compared to the reference group. CONCLUSION: Women with PCOS and endometriosis were more likely to be white, of lower socioeconomic status, lean, and experience abruptio-placenta, cesarean deliveries, and venous thromboembolisms. Since little was previously known about the combined outcomes of PCOS and endometriosis, it is difficult to counsel patients on risks. Our findings can help clinicians manage pregnant PCOS patients with endometriosis to minimize complications such as abruptio placenta and VTE.
Full text 9,407 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Purpose PCOS and endometriosis are independent risk factors for perinatal outcomes. Little research has evaluated the concomitant effects of these conditions, nor have studies been conducted on a population database. We sought to identify the pregnancy, delivery, and neonatal outcomes in women with polycystic ovary syndrome (PCOS) and endometriosis vs. PCOS without endometriosis.

Methods

A retrospective population-based cohort study was performed extracting data using ICD-9 codes from the HCUP-NIS Database from 2004 to 2014. Endometriosis in women with PCOS represented the study group (n = 163), and the remaining PCOS, non-endometriosis patients constituted the reference group (n = 14,719). Subjects were included once per delivery. Demographics were compared using chi-squared tests. Confounding effects in pregnancy outcomes were controlled using binary logistic regression analysis.

Results

Concomitant endometriosis and PCOS patients were more likely to be white (88.5% vs.71.0%, p < 0.001), with BMI < 30 kg/m2 (87.1% vs.77.8%, p < 0.004) and from lower income quartiles (27.1% vs.17.1%, p < 0.017) when compared to PCOS without endometriosis. Comparing pregnancy complication rates, placental abruption (p < 0.018, aOR 3.01, 95% CI 1.21–7.50), Cesarean section (p < 0.003, aOR 1.75, 95% CI 1.21–2.53), deep venous thromboses (p < 0.002, aOR 74.31, 95% CI 4.57–1209.21), and venous thromboembolic events (p < 0.031, aOR 10.40, 95% CI 1.24–87.37), were increased in the study group compared to the reference group.

Conclusion

Women with PCOS and endometriosis were more likely to be white, of lower socioeconomic status, lean, and experience abruptio-placenta, cesarean deliveries, and venous thromboembolisms. Since little was previously known about the combined outcomes of PCOS and endometriosis, it is difficult to counsel patients on risks. Our findings can help clinicians manage pregnant PCOS patients with endometriosis to minimize complications such as abruptio placenta and VTE. Similar content being viewed by others Data availability The HCUP data are publicly available.

References

Lalani S et al (2018) Endometriosis and adverse maternal, fetal and neonatal outcomes, a systematic review and meta-analysis. Hum Reprod 33(10):1854–1865 Liu X, Zhang J, Wang S (2024) Global, regional, and national burden of infertility attributable to PCOS, 1990–2019. Hum Reprod 39(1):108–118 Schliep KC et al (2023) Examining the co-occurrence of endometriosis and polycystic ovarian syndrome. AJOG Glob Rep 3(3):100259 Parasar P, Ozcan P, Terry KL (2017) Endometriosis: epidemiology, diagnosis and clinical management. Curr Obstet Gynecol Rep 6(1):34–41 Abu-Zaid A et al (2024) Association between endometriosis and obstetric complications: insight from the national Inpatient Sample. Eur J Obstet Gynecol Reprod Biol 292:58–62 Christ JP, Cedars MI (2023) Current guidelines for diagnosing PCOS. Diagnostics (Basel) 13(6):1113 Myers SH et al (2024) PCOS phenotype focus: phenotype D under the magnifying glass. Arch Gynecol Obstet 309(6):2307–2313 Farland LV et al (2022) Polycystic ovary syndrome and risk of adverse pregnancy outcomes: a registry linkage study from Massachusetts. Hum Reprod 37(11):2690–2699 Mills G et al (2020) Associations between polycystic ovary syndrome and adverse obstetric and neonatal outcomes: a population study of million births. Hum Reprod 35(8):1914–1921 Palomba S et al (2015) Pregnancy complications in women with polycystic ovary syndrome. Hum Reprod Update 21(5):575–592 Dinsdale NL, Crespi BJ (2021) Endometriosis and polycystic ovary syndrome are diametric disorders. Evol Appl 14(7):1693–1715 Franks S, Stark J, Hardy K (2008) Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 14(4):367–378 Salmeri N et al (2024) The kisspeptin system in and beyond reproduction: exploring intricate pathways and potential links between endometriosis and polycystic ovary syndrome. Rev Endocr Metab Disord 25(2):239–257 Zheng L et al (2023) Obesity and its impact on female reproductive health: unraveling the connections. Front Endocrinol (Lausanne) 14:1326546 Ferreira LZ et al (2024) A composite index; socioeconomic deprivation and coverage of reproductive and maternal health interventions. Bull World Health Organ 102(2):105–116 Hager M et al (2019) The prevalence of incidental endometriosis in women undergoing laparoscopic ovarian drilling for clomiphene-resistant polycystic ovary syndrome: a retrospective cohort study and meta-analysis. J Clin Med 8(8):1210 Tissot M et al (2017) Clinical presentation of endometriosis identified at interval laparoscopic tubal sterilization: prospective series of 465 cases. J Gynecol Obstet Hum Reprod 46(8):647–650 Rawson JM (1991) Prevalence of endometriosis in asymptomatic women. J Reprod Med 36(7):513–515 WHO. Endometriosis. 24 March 2023 27 May 2024. Farland LV et al (2017) Associations among body size across the life course, adult height and endometriosis. Hum Reprod 32(8):1732–1742 Holschbach V et al (2023) Patient- and cycle-specific factors affecting the outcome of frozen-thawed embryo transfers. Arch Gynecol Obstet 307(6):2001–2010 Koster MP et al (2015) Placental characteristics in women with polycystic ovary syndrome. Hum Reprod 30(12):2829–2837 Laschke MW, Menger MD (2018) Basic mechanisms of vascularization in endometriosis and their clinical implications. Hum Reprod Update 24(2):207–224 Szydelko-Gorzkowicz M et al (2022) The role of kisspeptin in the pathogenesis of pregnancy complications: a narrative review. Int J Mol Sci 23(12):6611 He Y et al (2016) Administration of atosiban in patients with endometriosis undergoing frozen-thawed embryo transfer: a prospective, randomized study. Fertil Steril 106(2):416–422 Leyendecker G et al (2004) Uterine peristaltic activity and the development of endometriosis. Ann N Y Acad Sci 1034:338–355 Jahromi BN et al (2018) Assessment of oxytocin level, glucose metabolism components and cutoff values for oxytocin and anti-mullerian hormone in infertile PCOS women. Taiwan J Obstet Gynecol 57(4):555–559 Maggiore LR, U. et al (2016) A systematic review on endometriosis during pregnancy: diagnosis, misdiagnosis, complications and outcomes. Hum Reprod Update 22(1):70–103 Tai W, Hu L, Wen J (2022) Maternal and neonatal outcomes after assisted reproductive technology: a retrospective cohort study in China. Front Med (Lausanne) 9:837762 Mills G et al (2020) Polycystic ovary syndrome as an independent risk factor for gestational diabetes and hypertensive disorders of pregnancy: a population-based study on 9.1 million pregnancies. Hum Reprod 35(7):1666–1674 Randeva HS et al (2012) Cardiometabolic aspects of the polycystic ovary syndrome. Endocr Rev 33(5):812–841 Ding D et al (2015) Platelets are an unindicted culprit in the development of endometriosis: clinical and experimental evidence. Hum Reprod 30(4):812–832 Mu F et al (2017) Association between endometriosis and hypercholesterolemia or hypertension. Hypertension 70(1):59–65 BahriKhomami M et al (2019) Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity—a systematic review, meta-analysis, and meta-regression. Obes Rev 20(5):659–674 Christ JP et al (2019) Pre-conception characteristics predict obstetrical and neonatal outcomes in women with polycystic ovary syndrome. J Clin Endocrinol Metab 104(3):809–818 Moore JE, Witt WP, Elixhauser A (2006) Complicating Conditions Associated With Childbirth, by Delivery Method and Payer, 2011, in Healthcare Cost and Utilization Project (HCUP) Statistical Briefs. Agency for Healthcare Research and Quality (US), Rockville Funding The authors declare that no funds, grants, or other support were received during the preparation of this manuscript. Author information Authors and Affiliations Contributions S Ismail: project development, data analysis, manuscript writing and editing. C Majdell: manuscript writing and editing. A Badgheish: data collection, management, and analysis. H Baghlaf: data collection and management. M Dahan: manuscript editing, project development, acted as the senior author for this study. Corresponding author Ethics declarations Conflict of interest The authors have no relevant financial or non-financial interests to disclose. Ethical approval Not applicable. Consent to participate Informed consent was obtained from all individual participants included in the study. Consent to publish Not applicable. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. About this article Cite this article Ismail, S., Majdell, C., Badgheish, A. et al. Pregnancy, delivery, and neonatal outcomes among women with PCOS and endometriosis: a population database cohort. Arch Gynecol Obstet 310, 1235–1243 (2024). https://doi.org/10.1007/s00404-024-07589-w Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s00404-024-07589-w

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis Endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (34)

Source provenance

europepmc
last seen: 2026-07-29T06:27:48.050232+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-07-29T06:25:25.499870+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK